Hologic, Inc. (0J5Q.L)
USD 72.51
(-0.3%)
USD 72.51
(-0.3%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 | 2.53 Billion USD | -10.06% |
| 2023 | 2.81 Billion USD | -3.54% |
| 2022 | 2.92 Billion USD | -7.09% |
| 2021 | 3.14 Billion USD | -0.08% |
| 2020 | 3.14 Billion USD | 1.15% |
| 2019 | 3.11 Billion USD | -7.51% |
| 2018 | 3.36 Billion USD | -0.61% |
| 2017 | 3.38 Billion USD | 0.04% |
| 2016 | 3.38 Billion USD | -7.22% |
| 2015 | 3.64 Billion USD | -15.24% |
| 2014 | 4.3 Billion USD | -11.11% |
| 2013 | 4.83 Billion USD | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q3 | 2.54 Billion USD | -0.99% |
| 2024 Q2 | 2.56 Billion USD | -0.37% |
| 2024 Q1 | 2.57 Billion USD | -11.23% |
| 2024 Q4 | 2.53 Billion USD | -0.33% |
| 2023 Q3 | 2.84 Billion USD | -0.13% |
| 2023 Q4 | 2.9 Billion USD | 2.25% |
| 2023 FY | 2.9 Billion USD | -0.6% |
| 2023 Q1 | 2.84 Billion USD | -2.53% |
| 2023 Q2 | 2.84 Billion USD | -0.14% |
| 2022 Q1 | 3.09 Billion USD | -1.64% |
| 2022 FY | 2.92 Billion USD | -7.09% |
| 2022 Q4 | 2.92 Billion USD | 2.71% |
| 2022 Q3 | 2.84 Billion USD | -8.04% |
| 2022 Q2 | 3.09 Billion USD | 0.01% |
| 2021 Q1 | 2.81 Billion USD | -10.59% |
| 2021 Q3 | 3.14 Billion USD | 12.37% |
| 2021 Q4 | 3.14 Billion USD | 0.11% |
| 2021 FY | 3.14 Billion USD | -0.08% |
| 2021 Q2 | 2.79 Billion USD | -0.58% |
| 2020 Q3 | 3.41 Billion USD | -6.91% |
| 2020 Q4 | 3.14 Billion USD | -7.83% |
| 2020 FY | 3.14 Billion USD | 1.15% |
| 2020 Q1 | 3.16 Billion USD | 1.76% |
| 2020 Q2 | 3.66 Billion USD | 15.89% |
| 2019 Q3 | 3.07 Billion USD | -1.83% |
| 2019 FY | 3.11 Billion USD | -7.51% |
| 2019 Q4 | 3.1 Billion USD | 1.13% |
| 2019 Q2 | 3.13 Billion USD | -0.55% |
| 2019 Q1 | 3.14 Billion USD | -6.33% |
| 2018 FY | 3.36 Billion USD | -0.61% |
| 2018 Q3 | 3.26 Billion USD | -3.08% |
| 2018 Q4 | 3.36 Billion USD | 2.82% |
| 2018 Q1 | 3.35 Billion USD | -0.82% |
| 2018 Q2 | 3.37 Billion USD | 0.61% |
| 2017 FY | 3.38 Billion USD | 0.04% |
| 2017 Q1 | 3.32 Billion USD | -1.7% |
| 2017 Q2 | 3.3 Billion USD | -0.48% |
| 2017 Q3 | 3.24 Billion USD | -1.9% |
| 2017 Q4 | 3.37 Billion USD | 4.18% |
| 2016 FY | 3.38 Billion USD | -7.22% |
| 2016 Q4 | 3.38 Billion USD | -1.23% |
| 2016 Q3 | 3.42 Billion USD | 0.48% |
| 2016 Q2 | 3.4 Billion USD | -6.24% |
| 2016 Q1 | 3.63 Billion USD | -0.38% |
| 2015 FY | 3.64 Billion USD | -15.24% |
| 2015 Q4 | 3.64 Billion USD | -7.51% |
| 2015 Q3 | 3.94 Billion USD | 0.06% |
| 2015 Q2 | 3.93 Billion USD | -0.38% |
| 2015 Q1 | 3.95 Billion USD | -8.07% |
| 2014 FY | 4.3 Billion USD | -11.11% |
| 2014 Q4 | 4.3 Billion USD | 0.73% |
| 2014 Q3 | 4.27 Billion USD | -0.07% |
| 2014 Q2 | 4.27 Billion USD | -0.66% |
| 2014 Q1 | 4.3 Billion USD | -11.11% |
| 2013 Q4 | 4.83 Billion USD | -3.3% |
| 2013 Q3 | 5 Billion USD | -0.0% |
| 2013 Q2 | 5 Billion USD | 0.0% |
| 2013 Q1 | - USD | 0.0% |
| 2013 FY | 4.83 Billion USD | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| Phreesia, Inc. | 11.98 Million USD | -21051.631% |
| Accuray Incorporated | 172.15 Million USD | -1372.269% |
| Align Technology, Inc. | 96.96 Million USD | -2513.852% |
| Elevance Health Inc. | 25.12 Billion USD | 89.91% |
| AxoGen, Inc. | 69.29 Million USD | -3557.854% |
| Boston Scientific Corporation | 9.09 Billion USD | 72.138% |
| CVS Health Corporation | 79.38 Billion USD | 96.807% |
| Cardinal Health, Inc. | 5.6 Billion USD | 54.812% |
| Centene Corporation | 17.69 Billion USD | 85.679% |
| DaVita Inc. | 11.11 Billion USD | 77.199% |
| HCA Healthcare, Inc. | 41.85 Billion USD | 93.945% |
| Humana Inc. | 10.21 Billion USD | 75.183% |
| IDEXX Laboratories, Inc. | 947.88 Million USD | -167.397% |
| Laboratory Corporation of America Holdings | 5.95 Billion USD | 57.432% |
| Masimo Corporation | 970 Million USD | -161.299% |
| McKesson Corporation | 5.47 Billion USD | 53.681% |
| Patterson Companies, Inc. | 762.94 Million USD | -232.215% |
| Quest Diagnostics Incorporated | 5.36 Billion USD | 52.792% |
| ResMed Inc. | 873.93 Million USD | -190.022% |
| Henry Schein, Inc. | 2.74 Billion USD | 7.53% |
| Teladoc Health, Inc. | 1.59 Billion USD | -59.181% |
| Universal Health Services, Inc. | 5.36 Billion USD | 52.771% |
| Veeva Systems Inc. | 55.77 Million USD | -4444.33% |
| Baxter International Inc. | 14.36 Billion USD | 82.354% |
| Becton, Dickinson and Company | 15.87 Billion USD | 84.038% |
| Intuitive Surgical, Inc. | 89.8 Million USD | -2722.494% |
| Danaher Corporation | 19.35 Billion USD | 86.905% |
| Stryker Corporation | 12.99 Billion USD | 80.496% |
| Medtronic plc | 24.96 Billion USD | 89.847% |